Investcorp buys Danish Sanos Group

The global alternative investment manager Investcorp has acquired the Danish contract research organization Sanos Group. Both firms confirm this to MedWatch.

Investcorp Principal Sebastian Inger | Photo: Investcorp / PR-foto

The Danish contract research organization Sanos Group, which delivers services for clinical trials within the pharmaceutical and biotech industries, has a new owner. The global manager of alternative investments Investcorp has acquired the company, which originally spun out of Nordic Bioscience and was owned by Claus Christiansen and Bente Christiansen.

Investcorp and Sanos Group both inform MedWatch of this event.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs